ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ROQ Roquefort Therapeutics Plc

4.55
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes

Roquefort Therapeutics Financial Summary

The current ROQ market cap is 5.88M. The company's latest EPS is GBP -0.0125 and P/E is -3.64.

Year End 31 December 2022 20212022
GBP (£)GBP (£)
Total Revenue 1,0000
Operating Income -916k-1.63M
Net Income -916k-1.62M
Year End 31 December 2022 20212022
GBP (£)GBP (£)
Total Assets 4.56M7.77M
Total Liabilities 477k561k
Total Equity 4.08M7.21M

Cash Flow

Year End 31 December 2022 20212022
GBP (£)GBP (£)
Operating -516k-1.58M
Investing -606k-103k
Financing 2.02M3.1M
Market Cap 5.88M
Price to Earnings Ratio -3.64
Price to Sales Ratio 0
Price to Cash Ratio 2.53
Price to Book Ratio 0.82
Dividend Yield -

Share Statistics

Shares Outstanding 129.15M
Average Volume (1 week) 330.73k
Average Volume (1 Month) 864.01k
52 Week Change -32.59%
52 Week High 9.25
52 Week Low 4.00
Spread (Intraday) 0.1 (2.17%)

Company Info

Company Name Roquefort Therapeutics Plc
Address eccleston yards
london SW1W 9NF
Website https://www.roquefortplc.com
Industry cmp integrated sys design (7373)

Your Recent History

Delayed Upgrade Clock